Were going to tackle some of the most common myths head-on, so you can have a clear and accurate picture of this innovative therapy
DHA Laboratory will send you a list of local LabCorp Patient Service Centers, patient prep instructions and a requisition form via email
A network meta-analysis published in the Journal of the Endocrine Society found retatrutide achieved 23.77% weight reduction compared to 16.79% for tirzepatide when standardized across trials, with absolute weight loss of 16.34 kg versus 11.82 kg
Because this payment demonstration operates outside coverage under a Part D plan, the $50 copayment toward these medications will not count toward a participating beneficiarys Part D deductible or the $2,100 out-of-pocket maximum in 2026 (increasing to $2,400 in 2027), and copayments will stay consistent at $50 per month, regardless of the Part D benefit phase a beneficiary is in when they fill the prescription
A few early studies suggest that GLP-1 drugs may also help protect against cancer